David Oleksyn

939 total citations
17 papers, 725 citations indexed

About

David Oleksyn is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, David Oleksyn has authored 17 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in David Oleksyn's work include NF-κB Signaling Pathways (5 papers), Developmental Biology and Gene Regulation (4 papers) and Melanoma and MAPK Pathways (3 papers). David Oleksyn is often cited by papers focused on NF-κB Signaling Pathways (5 papers), Developmental Biology and Gene Regulation (4 papers) and Melanoma and MAPK Pathways (3 papers). David Oleksyn collaborates with scholars based in United States, Norway and South Korea. David Oleksyn's co-authors include Robert C. Angerer, Lynne M. Angerer, Luojing Chen, Laurel Newman, Jiyong Zhao, Alan P. Kenny, Igñacio Sanz, Jim Miller, Mary J. Pulvino and Joël Shapiro and has published in prestigious journals such as The Journal of Cell Biology, Blood and PLoS ONE.

In The Last Decade

David Oleksyn

17 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Oleksyn United States 13 546 122 92 91 89 17 725
Gregory J. Dolecki United States 16 433 0.8× 79 0.6× 66 0.7× 232 2.5× 48 0.5× 23 778
Alessandro Coppe Italy 18 604 1.1× 100 0.8× 120 1.3× 191 2.1× 297 3.3× 29 1.1k
Lisa A. Urry United States 10 354 0.6× 85 0.7× 50 0.5× 109 1.2× 138 1.6× 11 849
Roger Revilla‐i‐Domingo Austria 9 285 0.5× 51 0.4× 35 0.4× 103 1.1× 20 0.2× 11 468
Andrew F. Giusti United States 13 246 0.5× 45 0.4× 66 0.7× 53 0.6× 12 0.1× 14 1.0k
Zi Fang China 10 276 0.5× 13 0.1× 107 1.2× 41 0.5× 92 1.0× 15 633
Kirsten Cooper United States 12 162 0.3× 44 0.4× 70 0.8× 111 1.2× 15 0.2× 31 633
Ying Tong China 19 392 0.7× 25 0.2× 52 0.6× 160 1.8× 146 1.6× 55 945
Shu-Yu Wu United States 13 288 0.5× 44 0.4× 24 0.3× 16 0.2× 33 0.4× 22 420
Dario Strbenac Australia 16 1.0k 1.9× 38 0.3× 19 0.2× 211 2.3× 256 2.9× 36 1.4k

Countries citing papers authored by David Oleksyn

Since Specialization
Citations

This map shows the geographic impact of David Oleksyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Oleksyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Oleksyn more than expected).

Fields of papers citing papers by David Oleksyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Oleksyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Oleksyn. The network helps show where David Oleksyn may publish in the future.

Co-authorship network of co-authors of David Oleksyn

This figure shows the co-authorship network connecting the top 25 collaborators of David Oleksyn. A scholar is included among the top collaborators of David Oleksyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Oleksyn. David Oleksyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Oleksyn, David, et al.. (2024). T cells use focal adhesions to pull themselves through confined environments. The Journal of Cell Biology. 223(10). 13 indexed citations
2.
Fettis, Margaret M., et al.. (2020). The CD28 Transmembrane Domain Contains an Essential Dimerization Motif. Frontiers in Immunology. 11. 1519–1519. 24 indexed citations
3.
Oleksyn, David, et al.. (2019). Robust blind spectral unmixing for fluorescence microscopy using unsupervised learning. PLoS ONE. 14(12). e0225410–e0225410. 47 indexed citations
4.
Oleksyn, David, Jiapeng Zhao, Aram Vosoughi, et al.. (2017). PKK deficiency in B cells prevents lupus development in Sle lupus mice. Immunology Letters. 185. 1–11. 3 indexed citations
5.
Chen, Luojing, Matthew S. Hayden, Elaine S. Gilmore, et al.. (2017). PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis. Carcinogenesis. 39(3). 418–428. 8 indexed citations
6.
Chen, Luojing, David Oleksyn, Mary J. Pulvino, et al.. (2016). A critical role for the protein kinase PKK in the maintenance of recirculating mature B cells and the development of B1 cells. Immunology Letters. 172. 67–78. 5 indexed citations
7.
Pulvino, Mary J., Luojing Chen, David Oleksyn, et al.. (2015). Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline. Oncotarget. 6(17). 14796–14813. 37 indexed citations
8.
Kim, Sang‐Woo, David Oleksyn, Craig T. Jordan, et al.. (2014). Protein kinase C-associated kinase regulates NF-κB activation through inducing IKK activation. International Journal of Oncology. 45(4). 1707–1714. 22 indexed citations
9.
Poligone, Brian, Elaine S. Gilmore, David Oleksyn, et al.. (2014). PKK Suppresses Tumor Growth and Is Decreased in Squamous Cell Carcinoma of the Skin. Journal of Investigative Dermatology. 135(3). 869–876. 15 indexed citations
10.
Oleksyn, David, Mary J. Pulvino, Jiyong Zhao, et al.. (2012). Protein Kinase Cβ Is Required for Lupus Development in Sle Mice. Arthritis & Rheumatism. 65(4). 1022–1031. 9 indexed citations
11.
Pulvino, Mary J., Yuejin Liang, David Oleksyn, et al.. (2012). Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood. 120(8). 1668–1677. 122 indexed citations
12.
Kim, Sang Woo, David Oleksyn, Randall M. Rossi, et al.. (2007). Protein kinase C–associated kinase is required for NF-κB signaling and survival in diffuse large B-cell lymphoma cells. Blood. 111(3). 1644–1653. 30 indexed citations
13.
Kenny, Alan P., David Oleksyn, Laurel Newman, Robert C. Angerer, & Lynne M. Angerer. (2003). Tight regulation of SpSoxB factors is required for patterning and morphogenesis in sea urchin embryos. Developmental Biology. 261(2). 412–425. 49 indexed citations
14.
Howard, Eric W., Laurel Newman, David Oleksyn, Robert C. Angerer, & Lynne M. Angerer. (2001). SpKrl: a direct target of β-catenin regulation required for endoderm differentiation in sea urchin embryos. Development. 128(3). 365–375. 80 indexed citations
15.
Angerer, Lynne M., et al.. (2001). Sea urchin goosecoid function links fate specification along the animal-vegetal and oral-aboral embryonic axes. Development. 128(22). 4393–4404. 96 indexed citations
16.
Angerer, Lynne M., David Oleksyn, Catriona Y. Logan, et al.. (2000). A BMP pathway regulates cell fate allocation along the sea urchin animal- vegetal embryonic axis. Development. 127(5). 1105–1114. 93 indexed citations
17.
Kenny, Alan P., David J. Kozlowski, David Oleksyn, Lynne M. Angerer, & Robert C. Angerer. (1999). SpSoxB1, a maternally encoded transcription factor asymmetrically distributed among early sea urchin blastomeres. Development. 126(23). 5473–5483. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026